Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs Sana Biotechnology, Inc. (SANA)

Janux Therapeutics, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. is the larger, with a market value of $758.1M against $686.2M — 1.1× the size. Sana Biotechnology, Inc. has the higher net margin (0.00% vs −300.0%) and the lower return on invested capital (−178.5% vs 0.00%). Across the 13 metrics below, Janux Therapeutics, Inc. leads on 8 and Sana Biotechnology, Inc. on 5.

Valuation

Metric JANX SANA Biotechnology median
P/E n/m n/m 11.58
P/S 23.60 n/m 9.61
P/B 0.86 3.91 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA 1.07 n/m 0.72
EV/Sales (4.81) n/m 9.43
Earnings yield (12.77%) (23.04%) (32.28%)
Free cash flow yield (6.90%) (20.42%) (22.27%)

Profitability

Metric JANX SANA Biotechnology median
Gross margin 100.00% 0.00% 68.81%
Operating margin (419.24%) 0.00% 0.00%
Net margin (299.95%) 0.00% 0.00%
Free cash flow margin (162.70%) 0.00% 0.00%
Return on equity (10.58%) (79.47%) (50.30%)
Return on assets (9.94%) (36.79%) (45.47%)
Return on invested capital 0.00% (178.50%) 0.00%

Growth

Metric JANX SANA Biotechnology median
Revenue growth (TTM) 214.40% — 6.78%
EPS growth (last fiscal year) (42.97%) 17.24% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JANX SANA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.69 1.77 4.74
Net debt to EBITDA 5.58 0.60 1.01

Dividend

Metric JANX SANA Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric JANX SANA Biotechnology median
Market cap 758.06m 686.16m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack